UBS Initiates Coverage On Afya with Neutral Rating, Announces Price Target of $19.5
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Andre Salles has initiated coverage on Afya (NASDAQ:AFYA) with a Neutral rating and set a price target of $19.5.
August 30, 2024 | 1:23 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
UBS has initiated coverage on Afya with a Neutral rating and a price target of $19.5, indicating a balanced view on the stock's potential.
The Neutral rating suggests that UBS sees Afya's stock as fairly valued at the current price, with the $19.5 target indicating limited upside. This may lead to a stable short-term price movement as the market digests this balanced outlook.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100